LeJeune Puetz Investment Counsel LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 1 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LeJeune Puetz Investment Counsel LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2022$110,000
-1.8%
2,2000.0%0.04%
+10.3%
Q1 2022$112,000
-48.9%
2,200
-38.9%
0.04%
-47.3%
Q4 2021$219,000
+8.4%
3,600
-14.3%
0.07%
+1.4%
Q3 2021$202,000
-8.6%
4,2000.0%0.07%
-11.0%
Q2 2021$221,000
+6.2%
4,2000.0%0.08%0.0%
Q1 2021$208,000
+2.0%
4,2000.0%0.08%
-6.8%
Q4 2020$204,000
-3.3%
4,2000.0%0.09%
-14.6%
Q3 2020$211,000
-1.4%
4,2000.0%0.10%
-8.0%
Q2 2020$214,000
+16.3%
4,2000.0%0.11%
+3.7%
Q1 2020$184,000
-12.8%
4,2000.0%0.11%
+9.1%
Q4 2019$211,000
+8.2%
4,2000.0%0.10%0.0%
Q3 2019$195,000
+7.1%
4,2000.0%0.10%
+5.3%
Q2 2019$182,000
-2.2%
4,2000.0%0.09%
-6.9%
Q1 2019$186,000
+2.2%
4,2000.0%0.10%
-10.6%
Q4 2018$182,000
-3.2%
4,2000.0%0.11%
+3.7%
Q3 2018$188,000
+11.9%
4,2000.0%0.11%
+4.8%
Q2 2018$168,0000.0%4,2000.0%0.10%
+1.0%
Q1 2018$168,000
-7.2%
4,2000.0%0.10%
-7.2%
Q4 2017$181,000
-15.0%
4,200
-1.8%
0.11%
-19.0%
Q3 2017$213,000
+12.1%
4,276
+7.5%
0.14%
+6.2%
Q2 2017$190,000
+5.6%
3,9760.0%0.13%0.0%
Q1 2017$180,000
+11.8%
3,9760.0%0.13%
+4.0%
Q4 2016$161,0003,9760.12%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Lagoda Investment Management, L.P. 2,100,140$25,968,0006.81%
Portolan Capital Management 664,298$8,214,0001.15%
GARRISON BRADFORD & ASSOCIATES INC 90,700$1,122,0001.10%
Opus Point Partners Management, LLC 72,009$890,0000.70%
Eagle Ridge Investment Management 122,500$1,515,0000.68%
EAM Investors, LLC 350,410$4,333,0000.51%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,881,667$60,362,0000.37%
Cannell & Co. 1,051,178$12,998,0000.37%
Birchview Capital, LP 42,300$523,0000.28%
Tekla Capital Management LLC 567,787$7,021,0000.25%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders